Acetaminophen enhances pruritus in a mouse model of contact dermatitis induced by suboptimal concentration of hapten

Katsunori Yamaura, Seri Akiyama, Manabu Oda, Eriko Suwa, Koichi Ueno

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Acetaminophen (APAP) is one of the most commonly used drugs worldwide to reduce fever, particularly in children. It is generally considered to be a safe drug. However, a number of studies have shown that regular use of APAP increases the risk of developing allergic diseases. Nonetheless, no animal models have been used to investigate these findings. Therefore, we aimed to create an animal model of APAP-induced pruritus in mice. APAP (0.25% and 0.5%) was administered via drinking water daily from infancy, and a suboptimal concentration of 2,4,6-trinitrochlorobenzene (TNCB) was applied repeatedly to each ear three times a week for 7 weeks to evoke chronic allergic contact dermatitis. Neither 0.25% nor 0.5% APAP was overtly hepatotoxic after 73 days of daily administration. Repeated challenge with TNCB evoked increase in the number of scratching bouts compared to day 1. This increase in the number of scratching bouts was significant in 0.25% and 0.5% APAP groups but not in the group treated with TNCB alone. Daily administration of 0.5% APAP significantly increased in the number of scratching bouts compared to TNCB alone on day 29. This animal model will be useful for investigating the mechanism underlying the increased risk of development of eczema caused by regular APAP use and for examining safer and more effective therapy with APAP.

Original languageEnglish
Pages (from-to)669-674
Number of pages6
JournalJournal of Toxicological Sciences
Volume36
Issue number5
DOIs
Publication statusPublished - 2011
Externally publishedYes

Fingerprint

Dermatitis
Haptens
Contact Dermatitis
Pruritus
Acetaminophen
Picryl Chloride
Animals
Animal Models
Allergic Contact Dermatitis
Eczema
Drinking Water
Pharmaceutical Preparations
Ear
Fever

Keywords

  • Acetaminophen
  • Allergic contact dermatitis
  • Animal model
  • Infant mice
  • Paracetamol
  • Pruritus

ASJC Scopus subject areas

  • Toxicology

Cite this

Acetaminophen enhances pruritus in a mouse model of contact dermatitis induced by suboptimal concentration of hapten. / Yamaura, Katsunori; Akiyama, Seri; Oda, Manabu; Suwa, Eriko; Ueno, Koichi.

In: Journal of Toxicological Sciences, Vol. 36, No. 5, 2011, p. 669-674.

Research output: Contribution to journalArticle

@article{a66e9bd00f24449bb698bd57a34c7b77,
title = "Acetaminophen enhances pruritus in a mouse model of contact dermatitis induced by suboptimal concentration of hapten",
abstract = "Acetaminophen (APAP) is one of the most commonly used drugs worldwide to reduce fever, particularly in children. It is generally considered to be a safe drug. However, a number of studies have shown that regular use of APAP increases the risk of developing allergic diseases. Nonetheless, no animal models have been used to investigate these findings. Therefore, we aimed to create an animal model of APAP-induced pruritus in mice. APAP (0.25{\%} and 0.5{\%}) was administered via drinking water daily from infancy, and a suboptimal concentration of 2,4,6-trinitrochlorobenzene (TNCB) was applied repeatedly to each ear three times a week for 7 weeks to evoke chronic allergic contact dermatitis. Neither 0.25{\%} nor 0.5{\%} APAP was overtly hepatotoxic after 73 days of daily administration. Repeated challenge with TNCB evoked increase in the number of scratching bouts compared to day 1. This increase in the number of scratching bouts was significant in 0.25{\%} and 0.5{\%} APAP groups but not in the group treated with TNCB alone. Daily administration of 0.5{\%} APAP significantly increased in the number of scratching bouts compared to TNCB alone on day 29. This animal model will be useful for investigating the mechanism underlying the increased risk of development of eczema caused by regular APAP use and for examining safer and more effective therapy with APAP.",
keywords = "Acetaminophen, Allergic contact dermatitis, Animal model, Infant mice, Paracetamol, Pruritus",
author = "Katsunori Yamaura and Seri Akiyama and Manabu Oda and Eriko Suwa and Koichi Ueno",
year = "2011",
doi = "10.2131/jts.36.669",
language = "English",
volume = "36",
pages = "669--674",
journal = "Journal of Toxicological Sciences",
issn = "0388-1350",
publisher = "Japanese Society of Toxicological Sciences",
number = "5",

}

TY - JOUR

T1 - Acetaminophen enhances pruritus in a mouse model of contact dermatitis induced by suboptimal concentration of hapten

AU - Yamaura, Katsunori

AU - Akiyama, Seri

AU - Oda, Manabu

AU - Suwa, Eriko

AU - Ueno, Koichi

PY - 2011

Y1 - 2011

N2 - Acetaminophen (APAP) is one of the most commonly used drugs worldwide to reduce fever, particularly in children. It is generally considered to be a safe drug. However, a number of studies have shown that regular use of APAP increases the risk of developing allergic diseases. Nonetheless, no animal models have been used to investigate these findings. Therefore, we aimed to create an animal model of APAP-induced pruritus in mice. APAP (0.25% and 0.5%) was administered via drinking water daily from infancy, and a suboptimal concentration of 2,4,6-trinitrochlorobenzene (TNCB) was applied repeatedly to each ear three times a week for 7 weeks to evoke chronic allergic contact dermatitis. Neither 0.25% nor 0.5% APAP was overtly hepatotoxic after 73 days of daily administration. Repeated challenge with TNCB evoked increase in the number of scratching bouts compared to day 1. This increase in the number of scratching bouts was significant in 0.25% and 0.5% APAP groups but not in the group treated with TNCB alone. Daily administration of 0.5% APAP significantly increased in the number of scratching bouts compared to TNCB alone on day 29. This animal model will be useful for investigating the mechanism underlying the increased risk of development of eczema caused by regular APAP use and for examining safer and more effective therapy with APAP.

AB - Acetaminophen (APAP) is one of the most commonly used drugs worldwide to reduce fever, particularly in children. It is generally considered to be a safe drug. However, a number of studies have shown that regular use of APAP increases the risk of developing allergic diseases. Nonetheless, no animal models have been used to investigate these findings. Therefore, we aimed to create an animal model of APAP-induced pruritus in mice. APAP (0.25% and 0.5%) was administered via drinking water daily from infancy, and a suboptimal concentration of 2,4,6-trinitrochlorobenzene (TNCB) was applied repeatedly to each ear three times a week for 7 weeks to evoke chronic allergic contact dermatitis. Neither 0.25% nor 0.5% APAP was overtly hepatotoxic after 73 days of daily administration. Repeated challenge with TNCB evoked increase in the number of scratching bouts compared to day 1. This increase in the number of scratching bouts was significant in 0.25% and 0.5% APAP groups but not in the group treated with TNCB alone. Daily administration of 0.5% APAP significantly increased in the number of scratching bouts compared to TNCB alone on day 29. This animal model will be useful for investigating the mechanism underlying the increased risk of development of eczema caused by regular APAP use and for examining safer and more effective therapy with APAP.

KW - Acetaminophen

KW - Allergic contact dermatitis

KW - Animal model

KW - Infant mice

KW - Paracetamol

KW - Pruritus

UR - http://www.scopus.com/inward/record.url?scp=80053490453&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053490453&partnerID=8YFLogxK

U2 - 10.2131/jts.36.669

DO - 10.2131/jts.36.669

M3 - Article

C2 - 22008542

AN - SCOPUS:80053490453

VL - 36

SP - 669

EP - 674

JO - Journal of Toxicological Sciences

JF - Journal of Toxicological Sciences

SN - 0388-1350

IS - 5

ER -